miR-203 inhibits ovarian tumor metastasis by targeting BIRC5 and attenuating the TGFβ pathway

about

miR-203 inhibits ovarian tumor metastasis by targeting BIRC5 and attenuating the TGFβ pathway

Item

http://www.wikidata.org/entity/Q58706941

description

im September 2018 veröffentlicher wissenschaftlicher Artikel

@de

scientific article published on 21 September 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

miR-203 inhibits ovarian tumor ...... d attenuating the TGFβ pathway

@en

miR-203 inhibits ovarian tumor ...... d attenuating the TGFβ pathway

@nl

type

Item

label

miR-203 inhibits ovarian tumor ...... d attenuating the TGFβ pathway

@en

miR-203 inhibits ovarian tumor ...... d attenuating the TGFβ pathway

@nl

prefLabel

miR-203 inhibits ovarian tumor ...... d attenuating the TGFβ pathway

@en

miR-203 inhibits ovarian tumor ...... d attenuating the TGFβ pathway

@nl

P1476

miR-203 inhibits ovarian tumor ...... d attenuating the TGFβ pathway

@en

P2093

Baojin Wang

http://www.w3.org/2001/XMLSchema#string

Guannan Zhao

http://www.w3.org/2001/XMLSchema#string

Hidemichi Watari

http://www.w3.org/2001/XMLSchema#string

Huan Yan

http://www.w3.org/2001/XMLSchema#string

Junming Yue

http://www.w3.org/2001/XMLSchema#string

Lawrence M Pfeffer

http://www.w3.org/2001/XMLSchema#string

Michelle Sims

http://www.w3.org/2001/XMLSchema#string

Wei Li

http://www.w3.org/2001/XMLSchema#string

Xia Li

http://www.w3.org/2001/XMLSchema#string

Yuqi Guo

http://www.w3.org/2001/XMLSchema#string

P2860

MicroRNA-203 suppresses cell proliferation and migration by targeting BIRC5 and LASP1 in human triple-negative breast cancer cells.

Mesothelium expression of vascular cell adhesion molecule-1 (VCAM-1) is associated with an unfavorable prognosis in epithelial ovarian cancer (EOC).

Pathway analysis of gene lists associated with platinum-based chemotherapy resistance in ovarian cancer: the big picture.

MicroRNA-7 inhibits tumor metastasis and reverses epithelial-mesenchymal transition through AKT/ERK1/2 inactivation by targeting EGFR in epithelial ovarian cancer

MiR-101 suppresses the epithelial-to-mesenchymal transition by targeting ZEB1 and ZEB2 in ovarian carcinoma

The EMT (epithelial-mesenchymal-transition)-related protein expression indicates the metastatic status and prognosis in patients with ovarian cancer.

Doxycycline inducible Krüppel-like factor 4 lentiviral vector mediates mesenchymal to epithelial transition in ovarian cancer cells.

MiR-506 inhibits multiple targets in the epithelial-to-mesenchymal transition network and is associated with good prognosis in epithelial ovarian cancer

Phase II, multicenter, open-label, randomized study of YM155 plus docetaxel as first-line treatment in patients with HER2-negative metastatic breast cancer.

CD151-α3β1 integrin complexes suppress ovarian tumor growth by repressing slug-mediated EMT and canonical Wnt signaling.

P2888

s13046-018-0906-0

P304

235

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13046-018-0906-0

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Peixin Dong

P577

2018-09-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1107123546

http://www.w3.org/2001/XMLSchema#string

P698

30241553

http://www.w3.org/2001/XMLSchema#string

P932

6150978

http://www.w3.org/2001/XMLSchema#string